The Enterprise Value as of November 2024 (TTM) for Generation Bio Co. (GBIO) is 163.63M

According to Generation Bio Co.’s latest financial reports and current stock price. The company's current Enterprise Value is 163.63M. This represents a change of -31.61% compared to the average of 239.27M of the last 4 quarters.

Generation Bio Co. (GBIO) Historical Enterprise Value (quarterly & annually)

How has GBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Generation Bio Co. over the last ten years is 462.28M. The current 163.63M Enterprise Value has changed 3.44% with respect to the historical average. Over the past ten years (40 quarters), GBIO's Enterprise Value was at its highest in in the September 2020 quarter at 1.35B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Generation Bio Co. (GBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Generation Bio Co. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Generation Bio Co. (GBIO) Average Enterprise Value

How has GBIO Enterprise Value performed in the past?

The current Enterprise Value of Generation Bio Co. (GBIO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Generation Bio Co. (GBIO) Enterprise Value vs. Peers

How is GBIO’s Enterprise Value compared to its peers?

Generation Bio Co.’s Enterprise Value is less than Monte Rosa Therapeutics, Inc. (439.72M), less than Nkarta, Inc. (201.38M), less than Lyell Immunopharma, Inc. (216.40M), less than Sana Biotechnology, Inc. (551.82M), greater than Kronos Bio, Inc. (5.32M), less than Erasca, Inc. (747.42M), less than C4 Therapeutics, Inc. (307.45M), less than Edgewise Therapeutics, Inc. (3.01B), greater than Century Therapeutics, Inc. (104.89M), greater than Passage Bio, Inc. (24.72M), greater than Homology Medicines, Inc. (-103303255.00), less than Stoke Therapeutics, Inc. (457.69M), less than Nuvation Bio Inc. (923.54M), greater than Shattuck Labs, Inc. (6.89M),

Build a custom stock screener for Generation Bio Co. (GBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Generation Bio Co. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Generation Bio Co. (GBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Generation Bio Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.